Story perspectives

Federal Tax Breaks for Medical Cannabis as DEA Reclassifies

4/25/2026

Summary

Story summary

The order gives the first federal tax deduction to businesses with state-licensed medical cannabis permits.
Acting Attorney General Todd Blanche signed the order on April 23, 2026, moving medical marijuana from Schedule I to Schedule III.
The reclassification does not legalize marijuana but creates an expedited registration path and sets a DEA hearing for June 29, 2026.
Critics, including 22 Republican senators and drug-policy groups, say the move could mislead and will challenge it legally.

History

Historical Context

California’s 1996 Proposition 215, approved by 56% of voters, created the nation’s first medical-cannabis program while federal law kept cannabis a Schedule I drug, prompting raids and the 2014 Rohrabacher–Farr amendment that limited prosecutions. Building on this state-federal clash, Acting Attorney General Todd Blanche’s 2026 order moved medical cannabis to Schedule III, enabling the first federal tax deduction for licensed dispensaries.

1 of 2

Story summary

The order gives the first federal tax deduction to businesses with state-licensed medical cannabis permits.
Acting Attorney General Todd Blanche signed the order on April 23, 2026, moving medical marijuana from Schedule I to Schedule III.
The reclassification does not legalize marijuana but creates an expedited registration path and sets a DEA hearing for June 29, 2026.
Critics, including 22 Republican senators and drug-policy groups, say the move could mislead and will challenge it legally.

1 / 2